These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
435 related items for PubMed ID: 16715137
21. Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations. Burger M, Denzinger S, Hammerschmied C, Tannapfel A, Maderstorfer A, Wieland WF, Hartmann A, Stoehr R. Eur Urol; 2006 Nov; 50(5):1102-9; discussion 1109-10. PubMed ID: 16413100 [Abstract] [Full Text] [Related]
22. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. Tsavachidou D, Coleman ML, Athanasiadis G, Li S, Licht JD, Olson MF, Weber BL. Cancer Res; 2004 Aug 15; 64(16):5556-9. PubMed ID: 15313890 [Abstract] [Full Text] [Related]
31. Raf: a strategic target for therapeutic development against cancer. Beeram M, Patnaik A, Rowinsky EK. J Clin Oncol; 2005 Sep 20; 23(27):6771-90. PubMed ID: 16170185 [Abstract] [Full Text] [Related]
32. Genetic similarities between Spitz nevus and Spitzoid melanoma in children. Gill M, Cohen J, Renwick N, Mones JM, Silvers DN, Celebi JT. Cancer; 2004 Dec 01; 101(11):2636-40. PubMed ID: 15503312 [Abstract] [Full Text] [Related]
37. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin. Zhang H, Pelzer AM, Kiang DT, Yee D. Cancer Res; 2007 Jan 01; 67(1):391-7. PubMed ID: 17210722 [Abstract] [Full Text] [Related]
38. Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade. Ogawa K, Sun C, Horii A. Oncol Rep; 2005 Dec 01; 14(6):1481-5. PubMed ID: 16273242 [Abstract] [Full Text] [Related]
39. Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity. Petti C, Molla A, Vegetti C, Ferrone S, Anichini A, Sensi M. Cancer Res; 2006 Jul 01; 66(13):6503-11. PubMed ID: 16818621 [Abstract] [Full Text] [Related]